KayoThera: Funding, Investors & Team (Oct 2026)
KayoThera, a biotechnology firm based in Princeton, New Jersey, specializes in creating treatments to heal advanced and metastatic cancers. Their initiatives focus on blocking an important enzyme that shields cancer cells and reducing regulatory T-cells, aiming to provide potential cures for previously untreatable cancers and instill optimism in patients. The company's primary goal is to develop pioneering immunotherapies and targeted therapies to ultimately bring about cures for advanced cancer cases. Founded in 2019, KayoThera is headquartered in Princeton, New Jersey.
KayoThera has raised $13.2M across 2 funding rounds on record, the most recent a Series A of $5.2M announced in Jul 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
KayoThera Company Profile and Key Stats
Latest funding round on record: Jul 2023.
KayoThera Funding Rounds
KayoThera raised $8.0M in a Series A announced in Mar 2022.
1.3 years later, a Series A of $5.2M was announced in Jul 2023.
KayoThera Founders and Leadership Team
Contact details for the KayoThera team: 1 of 1 has an email address on file.
Start 14-day free trial →KayoThera Funding Compared to Other Biotechnology Startups
KayoThera's latest round of $5.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like KayoThera in Biotechnology and Princeton
Companies Similar to KayoThera
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
KayoThera Funding FAQs
What does KayoThera do?
KayoThera, a biotechnology firm based in Princeton, New Jersey, specializes in creating treatments to heal advanced and metastatic cancers. Their initiatives focus on blocking an important enzyme that shields cancer cells and reducing regulatory T-cells, aiming to provide potential cures for previously untreatable cancers and instill optimism in patients. The company's primary goal is to develop pioneering immunotherapies and targeted therapies to ultimately bring about cures for advanced cancer cases. Founded in 2019, KayoThera is headquartered in Princeton, New Jersey.
How much funding has KayoThera raised?
KayoThera has raised $13.2M across 2 rounds on record. The most recent is a Series A of $5.2M announced in Jul 2023.
When did KayoThera last raise funding?
KayoThera's most recent funding round on record is a Series A of $5.2M, announced in Jul 2023.
Who founded KayoThera?
FundedIQ lists Mark Esposito (Founder) at KayoThera.
Where is KayoThera headquartered?
KayoThera is based in Princeton, New Jersey, United States.
How many employees does KayoThera have?
KayoThera is in the 1-10 employee band.
How does KayoThera's funding compare to other Biotechnology startups?
KayoThera's latest round of $5.2M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's KayoThera Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for KayoThera is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.